Beta2-agonist eutomers: a rational option for the treatment of asthma? - Wikidata - wikimedia - TriplyDB

Beta2-agonist eutomers: a rational option for the treatment of asthma?

Beta2-agonist eutomers: a rational option for the treatment of asthma?

http://www.wikidata.org/entity/Q44726379

about

Beta2-agonist eutomers: a rational option for the treatment of asthma?

http://www.wikidata.org/entity/Q44726379

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Beta2-agonist eutomers: a rational option for the treatment of asthma?

@en

Beta2-agonist eutomers: a rational option for the treatment of asthma?

@nl

type

label

Beta2-agonist eutomers: a rational option for the treatment of asthma?

@en

Beta2-agonist eutomers: a rational option for the treatment of asthma?

@nl

prefLabel

Beta2-agonist eutomers: a rational option for the treatment of asthma?

@en

Beta2-agonist eutomers: a rational option for the treatment of asthma?

@nl

P1433

Q44726379-825C3FF0-9FB6-4821-85DF-016C6D6B976D

P1476

Q44726379-6CFE688E-54FD-4AC8-B357-25E58EAB93B3

P2093

Q44726379-565B3243-1DAF-4615-AF08-0187F515FDF0

Q44726379-F2388931-243A-48B8-8BF1-E284AA6EACAA

P2860

Q44726379-05DB8BA8-F6F9-4BD0-80B5-25C9580EA70F

Q44726379-09BF3BD2-D0E4-44BB-B8B1-C86816C095E3

Q44726379-0D0EAF13-19C9-4670-97B8-D964E22CCB3B

Q44726379-18DC16D5-D66F-4A16-9E40-6464272FA65A

Q44726379-215128AC-1485-490F-9002-4E3408E41CDC

Q44726379-2BCBB12C-939B-4F05-A8E5-075DEC8E107D

Q44726379-2C443F8B-4AA2-4C8D-9B5E-8054AB392432

Q44726379-33AE259C-C5FA-4818-87F6-510472A4AF35

Q44726379-3EE218F4-E18C-41CB-9331-103569235DA2

Q44726379-478D8971-3D62-4FE2-B880-BFC4C951135B

P2888

Q44726379-9BC42097-1F6D-4F36-A233-A1973011602A

P304

Q44726379-BD497F6C-9EE5-48DF-A994-34F611DC02CF

P31

Q44726379-9ED2B528-F085-4744-B875-46B3C41C82C9

P356

Q44726379-A125258F-E184-4E5C-A5BE-55F831FDD2D2

P433

Q44726379-A15C57D2-3D26-4560-A717-C9C2E44DBD7C

P478

Q44726379-728F5D80-1A98-4EF7-A164-618BEFB78F0F

P577

Q44726379-E3F63912-9D2F-4A99-8A28-D74A14EA4EA0

P698

Q44726379-63B05F60-4950-4FEC-A2A3-BEDFEA9A7CE1

P921

Q44726379-25093F42-D3D0-4FB8-B8D9-4D66DD387DE8

P356

P1433

Treatments in Respiratory Medicine

P1476

Beta2-agonist eutomers: a rational option for the treatment of asthma?

@en

P2093

David W Boulton

http://www.w3.org/2001/XMLSchema#string

J Paul Fawcett

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

The pharmacokinetics of levosalbutamol: what are the clinical implications?

Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology.

The use of beta-agonists and the risk of death and near death from asthma.

Pharmacology of chiral compounds: 2-arylpropionic acid derivatives.

Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol.

Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.

Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.

P2888

P304

305-311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03256624

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14720033

http://www.w3.org/2001/XMLSchema#string

P921